Pharma R&D Annual Review 2018

May 15, 2018

Citeline’s Pharmaprojects’ Pharma R&D Annual Review 2018 is here! Tune into expert insights and score illuminating data on the trends that affected pharmaceutical R&D throughout 2017 and continue to shape the market today – for free.

Spotlight

Premas Biotech

Premas Biotech is a specialised protein services company offering services in cloning, expression, scale up & process development, and customised assay development. We are ISO9001:2008 company and cGMP compliant. We have done over 400 proteins in past 4.5 years. We have clients across the globe. We have worked successfully on vaccine development, vaccine carrier development, established 100 transient transfected work flow in mammalian cells, in licensed technologies to deliver >1 gram/L Mabs via transient transfected.

OTHER WHITEPAPERS
news image

Global Use of Medicines 2023

whitePaper | January 18, 2023

Reaching a post-pandemic era is an alluring prospect for almost everyone around the world after the disruptions of the past three years.

Read More
news image

PHARMACEUTICAL KEY ACCOUNT MANAGEMENT: HARNESSING SALES EXPERTISE TO DEVELOP UNIFIED STAKEHOLDER RELATIONSHIPS

whitePaper | November 25, 2022

To meet the needs of a growing range of external stakeholders, many life science companies are changing the ways that they disseminate information.

Read More
news image

Defragmenting Data for the Future of Pharma R&D

whitePaper | November 7, 2019

This in-depth paper will show you how to become data agile – tackling both technological issues and solutions, and the cultural and strategic framework needed around this to ensure success.

Read More
news image

The true impact of machine failure in pharma

whitePaper | November 24, 2022

Today’s pharmaceutical industry is facing big expectations and opportunities. Tasked with developing and manufacturing effective therapeutics and vaccines for an ongoing global pandemic,

Read More
news image

MOLECULAR GLUES LANDSCAPE IN DRUG DISCOVERY

whitePaper | June 21, 2022

nduced-proximity targeted protein degradation (TPD) is a ground-breaking strategy in drug discovery that has emerged during the last decade.

Read More
news image

Latest Evidence and Effects of Vitamin D3 (cholecalciferol)-Drug Interactions

whitePaper | October 15, 2022

Because vitamin D receptors are present in most cells in the body, its active form has potent effects on the growth and differentiation of many types of cells, meaning that vitamin D

Read More

Spotlight

Premas Biotech

Premas Biotech is a specialised protein services company offering services in cloning, expression, scale up & process development, and customised assay development. We are ISO9001:2008 company and cGMP compliant. We have done over 400 proteins in past 4.5 years. We have clients across the globe. We have worked successfully on vaccine development, vaccine carrier development, established 100 transient transfected work flow in mammalian cells, in licensed technologies to deliver >1 gram/L Mabs via transient transfected.

Events